Company Comparison
Tessera Therapeutics vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Tessera Therapeutics | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, MA | South San Francisco, California |
| Founded | 2018 | 2006 |
| Status | Active | Active |
| Last Funding Stage | Series B | — |
| Total Funding | $300M | — |
| Valuation | — | — |
What They Build
Tessera Therapeutics
Gene writing company developing a new class of genetic medicines that can write therapeutic messages into the genome to treat or cure diseases.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
Tessera Therapeutics
Sector Overlap
Both Tessera Therapeutics and 23andMe operate in Biotech.
Browse all Biotech companies →